Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Deciding between broad market and sector funds depends on diversification needs and risk tolerance. This guide compares outcomes and helps you decide.
28,547 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
GE Vernova’s stock slid after a mixed Q2 report, with earnings missing estimates but revenue beating forecasts. This ...
Northeast metros are clearing supply faster than many Sun Belt peers, boosting seller leverage as spring demand retur...
A major enterprise contract could transform D-Wave from a hardware play into a recurring-revenue champion. This artic...
Perplexity AI unveils a multi-scenario Solana forecast through 2026, highlighting faster networks and rising institut...
XRP has spent 2026 stuck between $1.30 and $1.50, with repeated tests at the ceiling and a steady floor around $1.38....
Investors are looking a decade out at XRP, weighing regulatory clarity, RippleNet expansion, and new use cases as the...
An AI forecast linked to Altman ChatGPT projects XRP moving into multi-dollar territory by late 2026, driven by regul...
Mullen’s share path remains highly uncertain as the EV market shifts and capital needs loom. This report maps potenti...
Bitcoin and XRP led a crypto rally after a Trump Iran-focused post, with BTC moving higher and XRP testing multi-week...
BP plc shares slipped as leadership changes hit the headlines and energy markets swung on oil-price moves. This artic...
A high-profile insider sale at Amplitude raises questions for investors. This guide breaks down what amplitude's co-f...